These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7051971)
1. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Gombert ME Antimicrob Agents Chemother; 1982 Jun; 21(6):1011-2. PubMed ID: 7051971 [TBL] [Abstract][Full Text] [Related]
2. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Gombert ME; Aulicino TM Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Gutmann L; Goldstein FW; Kitzis MD; Hautefort B; Darmon C; Acar JF Antimicrob Agents Chemother; 1983 Feb; 23(2):248-51. PubMed ID: 6340602 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins. Cynamon MH; Palmer GS Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams. Gombert ME; Aulicino TM; duBouchet L; Berkowitz LR Antimicrob Agents Chemother; 1987 Dec; 31(12):2013-4. PubMed ID: 3326528 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole. Gutiérrez Altés A; Díez Enciso M; Peña García P; Campos Bueno A Antimicrob Agents Chemother; 1982 Mar; 21(3):501-3. PubMed ID: 6980624 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility profile of soil isolates of Nocardia asteroides from Kuwait. Khan Z; Al-Sayer H; Chugh TD; Chandy R; Provost F; Boiron P Clin Microbiol Infect; 2000 Feb; 6(2):94-8. PubMed ID: 11168079 [TBL] [Abstract][Full Text] [Related]
9. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. Liñares J; Perez JL; Garau J; Murgui L; Martín R J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Dewsnup DH; Wright DN Antimicrob Agents Chemother; 1984 Feb; 25(2):165-7. PubMed ID: 6370125 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility patterns of Nocardia asteroides. Wallace RJ; Steele LC; Sumter G; Smith JM Antimicrob Agents Chemother; 1988 Dec; 32(12):1776-9. PubMed ID: 3072921 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole. Bennett JE; Jennings AE Antimicrob Agents Chemother; 1978 Apr; 13(4):624-7. PubMed ID: 352260 [TBL] [Abstract][Full Text] [Related]
13. Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients. Scopetti F; Iona E; Fattorini L; Goglio A; Franceschini N; Amicosante G; Orefici G J Chemother; 1994 Feb; 6(1):29-34. PubMed ID: 8071674 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents. McNamara BT; Meyer RD; Pasiecznik KA Antimicrob Agents Chemother; 1982 May; 21(5):753-7. PubMed ID: 6213196 [TBL] [Abstract][Full Text] [Related]
15. Synergistic action of trimethoprim and sulfamethoxazole for Nocardia asteroides: efficacious therapy in five patients. Adams HG; Beeler BA; Wann LS; Chin CK; Brooks GF Am J Med Sci; 1984; 287(1):8-12. PubMed ID: 6367470 [TBL] [Abstract][Full Text] [Related]
16. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Thompson RL; Fisher KA; Wenzel RP Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505 [TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Brown JE; Del Bene VE; Collins CD Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986 [TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)]. Grimm H Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]